Haemostasis and Urgent Surgical Care
VarmX B.V. focuses on clinical research in restoring coagulation for patients receiving factor Xa inhibitors or direct oral anticoagulants who need urgent surgery or invasive procedures with a high risk of bleeding.
- Bleeding control during urgent intervention
- Reversal of anticoagulation
- Perioperative haemostasis
The research activity is centered on clinical situations where rapid restoration of clotting function is needed to support procedural safety.
Anticoagulant Reversal in DOAC-Treated Patients
The sponsor investigates treatment options for patients on FXa DOACs who experience active bleeding or require urgent reversal before surgery, with attention to clinical use in emergency settings.
- Direct oral anticoagulant reversal
- Emergency bleeding management
- Urgent procedure readiness
These studies address the medical need for restoring normal clotting function in time-sensitive care pathways.
Perioperative Medicine and Invasive Procedures
Clinical research activity also extends to patients requiring urgent surgery or invasive procedures while receiving anticoagulant therapy, with emphasis on maintaining procedural haemostasis.
- Urgent surgery support
- Invasive procedure management
- Bleeding risk mitigation
This area reflects a therapeutic interest in managing anticoagulated patients in acute procedural settings.
